Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intravenous therapy.

C Waitt1, P Waitt, M Pirmohamed

  • 1Royal Liverpool and Broadgreen University Hospitals Trust, Liverpool, UK.

Postgraduate Medical Journal
|February 5, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Abstracts of the 26th International Workshop on Clinical Pharmacology of HIV, Hepatitis and other Antiviral Drugs 2025, 3-4 September 2025, Amsterdam, the Netherlands.

British journal of clinical pharmacology·2025
Same author

Trastuzumab deruxtecan adverse drug reactions reported to the UK's Medicines and Healthcare products Regulatory Agency via the Yellow Card Reporting System.

ESMO open·2025
Same author

Sex/gender differences in clinical pharmacology: A perspective from the IUPHAR World Smart Medication Day 2025.

Pharmacological research·2025
Same author

Recording of suspected adverse drug reaction reporting in veterinary free-text clinical narratives.

The Journal of small animal practice·2024
Same author

Best practices for the care of pregnant people living with TB.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2023
Same author

Pharmacogenomics of NSAID-Induced Upper Gastrointestinal Toxicity.

Frontiers in pharmacology·2021
Same journal

When polyuria follows methotrexate: drug-induced nephrogenic diabetes insipidus.

Postgraduate medical journal·2026
Same journal

Dapagliflozin-induced anaphylactic shock.

Postgraduate medical journal·2026
Same journal

Comparative efficacy of Janus kinase inhibitors in severe alopecia areata: a network meta-analysis based on randomized controlled trials.

Postgraduate medical journal·2026
Same journal

Two cases of toxic epidermal necrolysis with severe ocular involvement treated with adjunctive tofacitinib.

Postgraduate medical journal·2026
Same journal

Diastolic dysfunction and diabetes: the DIADAD study-a retrospective cohort study from Liverpool.

Postgraduate medical journal·2026
Same journal

Care, cash, and proof: forensic accountability for war-related starvation.

Postgraduate medical journal·2026
See all related articles

Intravenous (IV) therapy is common but can lead to serious complications or be unnecessary. This review outlines best practices for IV cannulation and therapy to improve patient outcomes and reduce hospital stays.

Area of Science:

  • Medical Practice
  • Patient Safety
  • Hospital Administration

Background:

  • Intravenous (IV) administration of fluids, drugs, and nutrition is a cornerstone of hospital care.
  • While generally safe, IV cannulation and therapy can lead to complications, including prolonged hospitalization and mortality.
  • There is evidence suggesting that many IV cannulations are performed without clear medical necessity.

Purpose of the Study:

  • To review the current landscape of intravenous therapy.
  • To identify and discuss potential complications associated with IV cannulation and therapy.
  • To outline evidence-based guidelines for good medical practice in IV therapy to enhance patient safety and optimize resource utilization.

Main Methods:

  • Literature review of existing studies and clinical guidelines on IV therapy.

Related Experiment Videos

  • Analysis of complication rates and reasons for unnecessary cannulation.
  • Synthesis of findings to formulate recommendations for best practice.

    • Main Results:

    • Complications from IV cannulation, such as infections and phlebitis, can significantly impact patient recovery times.
    • Unnecessary IV cannulations contribute to increased healthcare costs and potential patient harm.
    • Adherence to established protocols for IV access and therapy is crucial for minimizing risks.

    Conclusions:

    • Optimizing the use of IV therapy is essential for improving patient safety and healthcare efficiency.
    • Implementing evidence-based practices in IV cannulation and management can reduce complications and prevent unnecessary procedures.
    • Healthcare providers should critically evaluate the need for IV access and adhere to best practices throughout the therapy duration.